NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

末梢血管設備的全球市場 (2020年∼2027年)

Global Peripheral Vascular Devices Market - 2020-2027

出版商 DataM Intelligence 商品編碼 1004495
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
末梢血管設備的全球市場 (2020年∼2027年) Global Peripheral Vascular Devices Market - 2020-2027
出版日期: 2021年05月10日內容資訊: 英文 180 Pages
簡介

全球末梢血管設備市場主要促進因素是人口老齡化、呼吸系統疾病患者數量的增加、技術進步的結果以及生活方式相關疾病的傳播。特別是在中國、新加坡、印度和巴西等新興國家,由於監管體係不完善和市場競爭有限,預計市場將出現顯著增長。因此,產品製造商正在努力加強其在發展中國家的存在。但是,按地區劃分,北美擁有最大的市場份額。按類型分,外周血管支架和栓塞保護裝置佔很大份額。

本報告提供全球末梢血管設備的市場相關分析,提供市場規模趨勢預測,及各類型·各地區的詳細趨勢,主要的推動及阻礙市場要素,主要企業的簡介等相關調查。

目錄

第1章 全球末梢血管設備市場:分析方法·範圍

第2章 全球末梢血管設備市場:市場定義和概要

第3章 全球末梢血管設備市場:摘要整理

第4章 全球末梢血管設備市場:市場動態

  • 對市場的影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球末梢血管設備市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 價格分析
  • 法規分析
  • 醫療費償付分析
  • 未滿足需求
  • 專利趨勢

第6章 全球末梢血管設備市場:新型冠狀病毒感染疾病 (COVID-19)的分析

  • COVID-19對市場的影響分析
    • "COVID-19前" /過去的市場方案
    • "COVID-19中" /目前市場方案
    • "COVID-19後" /未來市場方案
  • COVID-19疫情中的價格趨勢
  • 需求與供給的變動階段
  • 感染擴大時政府的市場相關配合措施
  • 各製造公司的策略展開情形
  • 結論

第7章 全球末梢血管設備市場:各類型

  • 簡介
  • 市場規模的分析與與前一年同期相比成長率 (YoY):各類型
  • 市場向心力指數:各類型
    • 末梢血管支架
    • 經皮經管血管新生球囊
    • 導管
    • PTA導管導引線
    • 旋切術設備
    • 慢性完全閉塞設備
    • 主動脈支架
    • 手術用合成移植片
    • 栓塞保護設備
    • 下腔靜脈濾器

第8章 全球末梢血管設備市場:各地區

  • 簡介
  • 市場規模和與前一年同期相比成長率 (YoY):各地區
  • 市場向心力指數:各地區
  • 北美
    • 簡介
    • 域內市場固有趨勢
    • 市場規模·與前一年同期相比成長率 (YoY):各類型
    • 市場規模·與前一年同期相比成長率 (YoY):各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第9章 全球末梢血管設備市場:競爭情形

  • 競爭方案
  • 市場定位/佔有率分析
  • 企業合併·收購 (M&A)的分析

第10章 全球末梢血管設備市場:企業簡介

  • Abbott Laboratories
    • 企業概要
    • 產品的組合/概要
    • 近幾年趨勢
    • 財務分析:概要
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Blue Sail Medical Co., Ltd.
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group
  • Edwards Lifesciences Corporation
  • Medtronic Public Limited Company
  • Nipro Corporation
  • TE Connectivity LTD.
  • Terumo Corporation

第11章 全球末梢血管設備市場:重要考察

第12章 關於DataM Intelligence

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Overview

Peripheral vascular devices are used for the treatment of peripheral vascular diseases, which are slow and progressive blood circulation disorders caused by blockages, narrowing, or spasms in blood vessels outside the heart and brain, including arteries and veins. These devices are classified into peripheral vascular stents, percutaneous transluminal angioplasty balloons, PTA drug-eluting balloons, embolic protection devices, inferior vena cava filters, Aortic stent-grafts, synthetic surgical grafts, and peripheral guide wires.

The global peripheral vascular devices market size was worth US$ XX billion in 2019 and further predicted to reach US$ XX billion by 2027, at a CAGR of XX% during the forecast period (2020-2027).

Market Dynamics

The peripheral vascular devices market is projected to grow during the review period on account of the growing global geriatric population and respiratory disorders, technological advancements, and increasing lifestyle diseases is expected to boost the peripheral vascular devices market in the following years. The developing markets such as China, Singapore, India, and Brazil are likely to register high growth in the following years to come due to the presence of poor regulatory policies and limited competition. To leverage the high-growth opportunities in these markets, product manufacturers are strategically aiming to expand their presence in these emerging countries. Further, the rising competition in mature markets is further compelling players to focus on developing markets. The demand for medical devices in these countries is growing at a healthy rate when compared to developed countries, thus propelling the product demand.

The medical instruments business in developing economies is increasing significantly owing to the expansion of the private healthcare sector to cater to the needs of the growing middle-class population as well as the rising disposable incomes. The middle-class population in the Asia Pacific is projected to rise from 28% in 2009 to 66% by 2030. As a result of these trends, an increasing number of people in countries such as India and China can afford advanced treatments, including peripheral vascular diseases.

Rapid growth in the geriatric population

The sudden growth in the geriatric population is one of the factors driving the demand for peripheral vascular devices as this population segment is at a high risk of developing peripheral vascular diseases such as atherosclerosis and aneurysms. This is because age, genetic, and lifestyle factors lead to a buildup of plaque in the arteries. Globally, it is estimated that more than 200 million people are suffering from peripheral vascular diseases. Also, the prevalence of these diseases rises with an increase in age and is greater than 20% in the patient population aged above 80 years.

Technological advancement to boost the global peripheral vascular diseases market

The technological advancements in interventional devices, including stents and balloons, are expected to boost interventional cardiology & peripheral vascular devices market revenue. The manufacturing firms are increasing R&D expenditure to achieve sustainable competitiveness through innovation and development in their offerings. This will result into an increase in demand for advanced products to enhance the patient experience. Integrating nanotechnology and drug-eluting stents results in improving treatment efficiency.

COVID-19 Impact Analysis

COVID-19 pandemic has negatively affected the world economy by directly affecting production and demand, supply chain disruption, and financial impact. COVID-19 has adversely impacted the supply chain of suppliers and product manufacturers across the globe. In addition, the production sites shut down to prevent the risk of virus spread. Also, due to the lockdown in many countries, patient visits to hospitals have reduced significantly. Consequently, the number of diagnostic tests has plummeted. This has further reduced the sales of peripheral vascular devices. The overall increase in the prevalence of the peripheral vascular disease is expected to drive the peripheral vascular devices market size in the global market during the forecast period.

Segment Analysis

Based on the type, the peripheral vascular devices market has been classified into peripheral vascular stents, percutaneous transluminal angioplasty balloons, catheters, PTA guide wires, Atherectomy devices, chronic total acclusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters.

Peripheral Vascular Stents segment accounted for significant market share

The peripheral vascular stents segment recorded significant market share for the global peripheral vascular devices market, mainly due to innovations in stents such as the introduction of bioresorbable stents and stents developed with advanced materials to avoid restenosis. Moreover, the increasing number of angioplasties in countries such as China and India due to the large geriatric pool, high prevalence of cardiac disorders, and price capping are the main reasons which augment the stent segment growth.

Embolic protection devices garnered the largest share of the peripheral vascular devices market

The embolic protection devices segment accounted for the highest market share of the peripheral vascular device market. This is mainly attributed to the advantages of embolic protection devices over chronic total occlusion devices, such as the ability to capture embolic debris without interrupting continuous blood flow.

Geographical Analysis

Based on geography, the study analyzes the peripheral vascular devices market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America dominated the global peripheral vascular devices market throughout the forecast period

North America recorded the largest market share in the peripheral vascular devices market, followed by Europe and Asia-Pacific. Factors that lead to an increase are the increasing prevalence of peripheral artery diseases, aortic aneurysms, and pulmonary embolisms; the rising number of obese & diabetic populations; and the presence of key players are leading the growth of this regional segment.

Asia-Pacific, on the other hand, is expected to be the most attractive regional peripheral vascular devices market due to a large presence of patients with unmet medical needs. Moreover, growth in healthcare infrastructure and patient disposable income levels in emerging markets, such as India and China, are expected to serve the overall market of peripheral vascular devices.

Competitive Landscape

The global peripheral vascular devices market is highly competitive due to the presence of big brands. The key players operating in the peripheral vascular devices market are Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), B. Braun Melsungen AG (Germany), Blue Sail Medical Co., Ltd. (China), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), Cardinal Health, Inc. (U.S.), Cook Group (U.S.), iVascular (Spain), Koninklijke Philips N.V. (Netherlands), Edwards Lifesciences Corporation (U.S.), Nipro Corporation (Japan), TE Connectivity LTD. (Switzerland), Medtronic Public Limited Company (Ireland), and Terumo Corporation (Japan), among others.

Abbott Laboratories

Overview: Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company is engaged in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on diabetes care, neuromodulation, diagnostics, nutrition & medicine. The company's product portfolio comprises FreeStyle, Pedialyte, EleCare, Juven, and Glucerna. These products are directly sold to distributors, wholesalers, pharmacies, health care facilities, government agencies, and independent retailers from company-owned distribution centers & public warehouses. The cardiovascular products further include MitraClip, Portico, Dilatation Catheter, among others. The diagnostics products include Vysis ALK, IntelliFISH, PathVysion, STARLIMS, AlinIQ, among others. The Company's headquarter is located in Illinois, United States.

Product Portfolio: The Company's portfolio comprises the therapeutic areas of cardiovascular, diabetes, diagnostics, neuromodulation, nutrition, and pharmaceuticals.

Why Purchase the Report?

  • Visualize the peripheral vascular devices market segmentation composition by type, and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the peripheral vascular devices market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of peripheral vascular devices market - level 2 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players.

The global peripheral vascular devices market report would provide access to an approx: 52 market data table, 44 figures, and 210 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Peripheral Vascular Devices Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Peripheral Vascular Devices Market - Market Definition and Overview

3. Global Peripheral Vascular Devices Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Region

4. Global Peripheral Vascular Devices Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rapidly increase in the aging population.
      • 4.1.1.2. Rising incidence rate of peripheral vascular disease (PVD)
      • 4.1.1.3. Increase in demand for minimally invasive endovascular procedures.
      • 4.1.1.4. Increase in specialists treating PVD.
    • 4.1.2. Restraints:
      • 4.1.2.1. Infections from peripheral vascular implantations
      • 4.1.2.2. Strict approval process from government bodies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Peripheral Vascular Devices Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. Global Peripheral Vascular Devices Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Peripheral Vascular Devices Market - By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Peripheral vascular stents*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Percutaneous transluminal angioplasty balloons
    • 7.3.3. Catheters
    • 7.3.4. PTA guide wires
    • 7.3.5. Atherectomy devices
    • 7.3.6. Chronic total occlusion devices
    • 7.3.7. Aortic stents
    • 7.3.8. Synthetic surgical grafts
    • 7.3.9. Embolic protection devices
    • 7.3.10. Inferior vena cava filters

8. Global Peripheral Vascular Devices Market - By Region

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 8.3. Market Attractiveness Index, By Region
  • 8.4. North America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.4.1. U.S.
      • 8.4.4.2. Canada
      • 8.4.4.3. Mexico
  • 8.5. Europe
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.4.1. Germany
      • 8.5.4.2. U.K.
      • 8.5.4.3. France
      • 8.5.4.4. Italy
      • 8.5.4.5. Spain
      • 8.5.4.6. Rest of Europe
  • 8.6. South America
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
    • 8.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.6.6.1. Brazil
      • 8.6.6.2. Argentina
      • 8.6.6.3. Rest of South America
  • 8.7. Asia Pacific
    • 8.7.1. Introduction
    • 8.7.2. Key Region-Specific Dynamics
    • 8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.7.4.1. China
      • 8.7.4.2. India
      • 8.7.4.3. Japan
      • 8.7.4.4. Australia
      • 8.7.4.5. Rest of Asia Pacific
  • 8.8. Middle East and Africa
    • 8.8.1. Introduction
    • 8.8.2. Key Region-Specific Dynamics
    • 8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9. Global Peripheral Vascular Devices Market - Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Global Peripheral Vascular Devices Market - Company Profiles

  • 10.1. Abbott Laboratories*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. B. Braun Melsungen AG
  • 10.3. Becton, Dickinson and Company
  • 10.4. BIOTRONIK SE & Co. KG
  • 10.5. Blue Sail Medical Co., Ltd.
  • 10.6. Boston Scientific Corporation
  • 10.7. Cardinal Health, Inc.
  • 10.8. Cook Group
  • 10.9. Edwards Lifesciences Corporation
  • 10.10. Medtronic Public Limited Company
  • 10.11. Nipro Corporation
  • 10.12. TE Connectivity LTD.
  • 10.13. Terumo Corporation

LIST NOT EXHAUSTIVE

11. Global Peripheral Vascular Devices Market - Premium Insights

12. Global Peripheral Vascular Devices Market - MSG

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us